Pfizer building scare tests office-to-resi thesis
For an industry betting that obsolete office towers can help solve the housing shortage, this week’s scare at the former Pfizer headquarters could be a snag. Work stopped at the Midtown Manhattan tower on Tuesday after two steel columns failed during construction, prompting evacuations of the site and neighboring properties. The project, led by Nathan Berman’s MetroLoft and David Werner, is slated to deliver roughly 1,600 apartments, making it one of the city’s most closely watched office conversion projects. Work was quickly launched to shore up and stabilize the building. Nobody was injured in the incident and Berman anticipates a […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts

Why this Brooklyn project is nowhere to be seen

Elliman’s AI overhaul raises questions about future of
agents

NY Dirt: Owners have a lot of pied-à-terre questions

NYC’s top deals: UWS megamansion trades for $40M — nearly
50% off asking

UWS double-wide sells for $45M, sets neighborhood townhouse
record

BroadRange Logistics sued for tenant improvement fraud
scheme

Trump administration rejects Congress’ plan, threatening
vouchers

Chelsea NYCHA redevelopment greenlit after court lifts
pause

Nathan Berman communicating with investors over Pfizer
project


